Cara Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Depomed DEPO:US USD 66.4M 421K
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Horizon Pharma HZNP:US USD 2.55B 2.3M
JAZZ PHA JAZZ:US USD 5.69B 2.47M
Pacira Pharmaceuticals PCRX:US USD 655.82M 58.18M
Revance Therapeutics RVNC:US USD 379.37M 485K
Teva Pharmaceutical Industries TEVA:US USD 19.1B 606M